glp-1 news today october 20 2025 Drugs: A New Clue in Inflammation, Blood Cancer, and Cancer Risk GLP-1 Weight-Loss Drug Demonstration Begins

Subtle conformational dynamics allow the C-terminus of GLP-1 to access the ECD binding site, and the ligand binding triggers further dissociation of the ECD from the TMD allowing the N-terminus of GLP-1 to enter the orthosteric pocket in the TMD and activate the receptor

Low iron can restrict oxygen supply to hair follicles, leading to thinning and shedding

It adds that health professionals have a key role in identifying and managing the risks associated with unregistered GLP-1 products and should advise patients accordingly

Accessed 16 Nov 2023

Authors demonstrated that the novel peptide inhibitor of DPP-IV (Tyr-Pro-D-Ala-NH 2 ) blocks DPP-IV activity and attenuates acute, semi-chronic, and relapsing TNBS- and DSS-induced colitis in mice after topical administration (Salaga et al